Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia

被引:1
|
作者
Neupane, Niraj [1 ]
Low, Soon K. [2 ]
Kharel, Himal [1 ]
Bhattarai, Sanket [3 ]
Thapa, Sangharsha [4 ]
Mahmoud, Amir [1 ]
Pokhrel, Nishant B. [5 ]
Din, Mohammad Ammad Ud [6 ]
Kouides, Peter [7 ]
机构
[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY 14621 USA
[2] Med Coll Wisconsin, Dept Hematol & Oncol, Milwaukee, WI USA
[3] Mayo Clin, Rochester, MN USA
[4] New York Med Coll, Westchester Med Ctr, Dept med, Westchester, NY USA
[5] Norwalk Hosp, Dept Internal Med, Norwalk, CT USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Oncol, Tampa, FL USA
[7] Rochester Gen Hosp, Lipson Canc Inst, Dept Hematol, Rochester, NY USA
关键词
PROGNOSIS; SUBTYPES;
D O I
10.1002/ajh.27148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E26 / E28
页数:3
相关论文
共 50 条
  • [21] Frequency and Prognosis of JAK2 V617F, Calr, MPL and ASXL1 Mutations in Primary Myelofibrosis
    Sorigue, Marc
    Cabezon, Marta
    Garcia, Olga
    Velez, Patricia
    Marce, Silvia
    Boque, Concha
    Xicoy, Blanca
    Fernandez, Cristalina
    Xandri, Marisol
    Casanova, Enric
    Gallardo, David
    Milla, Fuensanta
    Ribera, Josep-Maria
    Feliu, Evarist
    Zamora, Lurdes
    BLOOD, 2014, 124 (21)
  • [22] COEXISTING JAK2 AND CALR MUTATIONS IN ESSENTIAL THROMBOCYTHEMIA: CASE REPORT
    Arantes, Regina
    Li, Fernanda
    Seixas, Filipa
    Cunha, Manuel
    Moutinho, Osvaldo
    Pinto-Leite, Rosario
    MEDICINE, 2022, 101 (30)
  • [23] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [24] Calr Is up-Regulated in Patients with Essential Thrombocythemia Independently from Calr and JAK2 Mutations
    Brown, Lilia
    Graham, Ciaren
    Rinaldi, Ciro
    BLOOD, 2014, 124 (21)
  • [25] JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia
    Pich, Achille
    Riem, Ludovica
    di Celle, Paola Francia
    Beggiato, Eloise
    Benevolo, Gmlia
    Godio, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S46 - S46
  • [26] JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia
    Wang, Jing
    Zhang, Biao
    Chen, Bing
    Zhou, Rong-Fu
    Zhang, Qi-Guo
    Li, Juan
    Yang, Yong-Gong
    Zhou, Min
    Shao, Xiao-Yan
    Xu, Yong
    Xu, Xi-Hui
    Ouyang, Jian
    Xu, Jingyan
    Ye, Qing
    HEMATOLOGY, 2017, 22 (03) : 145 - 148
  • [27] Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia
    De Stefano, Valerio
    Za, Tommaso
    Rossi, Elena
    Fiorini, Alessia
    Ciminello, Angela
    Luzzi, Claudia
    Chiusolo, Patrizia
    Sica, Simona
    Leone, Giuseppe
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 733 - 737
  • [28] JAK2, MPL, AND CALR MUTATIONS IN CHINESE HAN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Xu, J.
    HAEMATOLOGICA, 2016, 101 : 814 - 814
  • [29] Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia
    Kang, Min-Gu
    Choi, Hyun-Woo
    Lee, Jun Hyung
    Choi, Yong Jun
    Choi, Hyun-Jung
    Shin, Jong-Hee
    Suh, Soon-Pal
    Szardenings, Michael
    Kim, Hye-Ran
    Shin, Myung-Geun
    ONCOTARGET, 2016, 7 (35) : 57036 - 57049
  • [30] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    Antonioli, E
    Guglielmelli, P
    Pancrazzi, A
    Bogani, C
    Verrucci, M
    Ponziani, V
    Longo, G
    Bosi, A
    Vannucchi, AM
    LEUKEMIA, 2005, 19 (10) : 1847 - 1849